Sustained-release praziquantel tablet: Pharmacokinetics and the treatment of clonorchiasis in beagle dogs

Parasitology Research

Volumn 91, Issue 4, 2003, Pages 316-320

  Hong, Sung Tae ^a   Lee, Sang Hyup ^a   Lee, Seung Jin ^b   Kho, Weon Gyu ^c   Lee, Mejeong ^a   Li, Shunyu ^a   Chung, Byung Suk ^a   Seo, Min ^d   Choi, Min Ho ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Ewha Womans University   (South Korea)

^c Inje University College of Medicine   (South Korea)

^d Dankook University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYPROPYLMETHYLCELLULOSE; PRAZIQUANTEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CLONORCHIASIS; CLONORCHIS SINENSIS; CONTROLLED STUDY; DOG; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG FORMULATION; DRUG SOLUBILITY; NONHUMAN; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; TABLET; TREATMENT OUTCOME;

ANIMALS; ANTHELMINTICS; AREA UNDER CURVE; CLONORCHIASIS; CLONORCHIS SINENSIS; DISEASE MODELS, ANIMAL; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; PARASITIC DISEASES, ANIMAL; PRAZIQUANTEL; TABLETS, ENTERIC-COATED; TREATMENT OUTCOME;

ANIMALIA; CANIS FAMILIARIS; CESTODA; CLONORCHIS SINENSIS; TREMATODA;

EID: 0242266127     PISSN: 09320113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00436-003-0958-7     Document Type: Article

References (15)

1. Andrews P (1985) Praziquantel: mechanisms of anti-schistosomal activity. Pharmacol Ther 29:129-156
2. Andrews P, Thomas H, Pohlke R, Seubert J (1983) Praziquantel. Med Res Rev 3:147-200
3. Conlon CP, Ellis CJ (1985) Praziquantel. J Antimicrob Chemother 15:1-2
4. Fallon PG, Cooper RO, Probert AJ, Doenhoff MJ (1992) Immune-dependent chemotherapy of schistosomiasis. Parasitology 105 [Suppl]:S41-S48
5. Hong ST, Yoon K, Lee M, Seo M, Choi MH, Sim JS, Choi BI, Yun CK, Lee SH (1998) Control of clonorchiasis by repeated praziquantel treatment and low diagnostic efficacy of sonography. Korean J Parasitol 36:249-254
6. Hong ST, Rim HJ, Min DY, Li X, Xu J, Feng Z, Lee SH (2001) Control of clonorchiasis by repeated treatments with praziquantel. Korean J Parasitol 39:285-292
7. Maggi L, Machiste EO, Torre ML, Conte U (1999) Formulation of biphasic release tablets containing slightly soluble drugs. Eur J Pharm Biopharm 48:37-42
8. Mahmoud AA (1987) Praziquantel for the treatment of helminthic infections. Adv Intern Med 32:193-206
9. Mehlhorn H, Kojima S, Rim HJ, Ruenwongsa P, Andrews P, Thomas H, Bunnag B (1983) Ultrastructural investigations on the effects of praziquantel on human trematodes from Asia: Clonorchis sinensis, Metagonimus yokogawai, Opisthorchis viverrini, Paragonimus westermani and Schistosoma japonicum. Arzneimittelforschung 33:91-98
10. Ministry of Health and Welfare/Korea Association of Health (1997) Prevalence of intestinal parasitic infections in Korea - the sixth report. Ministry of Health and Welfare/Korea Association of Health, Seoul
11. Niels T, Nguyen VD, Ha VV, Le VC, Nguyen DT, Piet AK, Peter JV (1999) Little effect of praziquantel or artemisinin on clonorchiasis in northern Vietnam. A pilot study. Trop Med Intern Health 4:814-818
12. Rim HJ (1986) The current pathobiology and chemotherapy of clonorchiasis. Korean J Parasitol 28 [Suppl]:5-141
13. Rim HJ, Lyu KS, Lee JS, Joo KH (1981) Clinical evaluation of the therapeutic efficacy of praziquantel (Embay 8440) against Clonorchis sinensis infection in man. Ann Trop Med Parasitol 75:27-33
14. Seo BS, Lee SH, Chai JY, Hong ST (1983) Praziquantel (Distocide) in treatment of Clonorchis sinensis infection. Korean J Parasitol 21:241-245
15. Wahn V, Mehlhorn H (1984) Four kinds of parasites in an 8-year-old boy. Therapeutic effects of praziquantel against Fasciola hepatica. Dtsch Med Wochenschr 109:1486-1488